Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Marsa
    Junior Member
    • Oct 2011
    • 3

    #16
    coverage is around 10X with unique and filtered reads.

    Comment

    • lahoman
      Member
      • Jan 2011
      • 12

      #17
      Hi there,

      I am confused with my RNASeq analysis result. After mapping the reads to Human reference using TopHat, 62% is mapped to the intronic or intergeneric region.

      Here is short summary about my experiment:
      1. Extract total RNA using Qiagen RNAmini kit
      2. Prepare library using Illumina TrueSeq protocol

      I am wondering maybe this is due to the high amount of premature mRNA. How do you think? Does anyone have the simillar experience? Any comment is welcome.

      Thank you so much for your attention,

      Lahoman

      Comment

      • Jeremy
        Senior Member
        • Nov 2009
        • 190

        #18
        What portion of the reads mapped to intergenic regions? Were those regions close to or distant from genes? Perhaps the DNA digestion step in your RNA extraction failed and you actually sequenced a mix of DNA and mRNA. Check the genomic regions where the reads map to for poly-A runs.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Yesterday, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        71 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...